News

HypGen Inc to Present during Biotech ShowcaseTM 2018

View Release


HypGen, Inc., Formerly Mega Bridge, Inc., Announces Change of Stock Ticker Symbol to HPGN

View Release


Mega Bridge, Inc. Announces Name Change to HypGen, Inc. and New Strategic Direction

HypGen to focus on developing treatments for Parkinson’s Disease; new strategy to be spearheaded by incoming CEO, Dr. McCoy L. Moretz
View Release